Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
Advantage Solutions A | ADV | 5. nov 2024 | 3.27 | +1.24 |
Advent | AVK | 5. nov 2024 | 11.30 | +0.53 |
Advent Technologies A | ADN | 5. nov 2024 | 3.56 | +6.27 |
Adverum Biotechnologies | ADVM | 5. nov 2024 | 7.72 | +2.39 |
AdvisorShares Pure US Cannabis ETF | MSOS | 5. nov 2024 | 6.87 | -4.32 |
Advisorshares Star Global Buy-Write ETF | VEGA | 5. nov 2024 | 43.58 | +0.80 |
AECOM | ACM | 5. nov 2024 | 109.91 | +1.73 |
Aegon N.V ADR | AEG | 5. nov 2024 | 6.42 | +1.10 |
Aehr Test Systems | AEHR | 5. nov 2024 | 12.11 | +3.46 |
Aemetis | AMTX | 5. nov 2024 | 3.15 | +12.50 |
Aeon Biopharma | AEON | 5. nov 2024 | 0.88 | -0.25 |
AerCap Holdings | AER | 5. nov 2024 | 95.66 | +1.83 |
Aeries Technology | AERT | 5. nov 2024 | 1.60 | -3.03 |
Aerospace & Defense Powershares | PPA | 5. nov 2024 | 116.36 | +1.57 |
Aerovate Therapeutics | AVTE | 5. nov 2024 | 2.70 | -0.74 |
AeroVironment | AVAV | 5. nov 2024 | 219.67 | +1.94 |
AerSale | ASLE | 5. nov 2024 | 5.71 | +5.35 |
AES | AES | 5. nov 2024 | 15.51 | +1.84 |
Aetherium Acquisition A | GMFI | 5. nov 2024 | 11.04 | 0.00 |
Aetherium Acquisition Unit | GMFIU | 5. nov 2024 | 11.10 | 0.00 |
Aethlon Medical | AEMD | 5. nov 2024 | 0.39 | -3.01 |
Aeva Technologies | AEVA | 5. nov 2024 | 4.05 | +5.19 |
AEye A | LIDR | 5. nov 2024 | 1.14 | +7.55 |
Affiliated Managers Group | AMG | 5. nov 2024 | 177.76 | +0.40 |
Affimed N.V. | AFMD | 5. nov 2024 | 3.66 | +11.93 |
Affinity Bancshares | AFBI | 5. nov 2024 | 21.93 | +2.48 |
Affirm A | AFRM | 5. nov 2024 | 45.60 | +4.37 |
Aflac | AFL | 5. nov 2024 | 105.56 | +1.00 |
Africa Index ETF Market Vectors | AFK | 5. nov 2024 | 16.73 | +1.58 |
Afya A | AFYA | 5. nov 2024 | 18.09 | +2.61 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.